Relationship between plasma circulating cell-free DNA concentration and treatment outcomes including prognosis in patients with advanced non-small cell lung cancer

被引:0
|
作者
Wei-Wei Peng
Ying Liu
Huan-Huan Sha
Shao-Di Wen
Ying Fang
Guo-Ren Zhou
机构
[1] Jiangsu Institute of Cancer Research,Jiangsu Cancer Hospital
[2] The Affiliated Cancer Hospital of Nanjing Medical University,undefined
来源
关键词
Non-small cell lung cancer (NSCLC); Plasma cell-free DNA (cfDNA); Prognosis biomarkers;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Circulating Cell-free DNA as a Prognostic Biomarker in Patients with Advanced ALK plus Non-small Cell Lung Cancer in the Global Phase III ALEX Trial
    Dziadziuszko, Rafal
    Peters, Solange
    Mok, Tony
    Camidge, D. Ross
    Gadgeel, Shirish M.
    Ou, Sai-Hong Ignatius
    Konopa, Krzysztof
    Noe, Johannes
    Nowicka, Malgorzata
    Bordogna, Walter
    Morcos, Peter N.
    Smoljanovic, Vlatka
    Shaw, Alice T.
    CLINICAL CANCER RESEARCH, 2022, 28 (09) : 1800 - 1808
  • [32] Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy
    Coco, Simona
    Alama, Angela
    Vanni, Irene
    Fontana, Vincenzo
    Genova, Carlo
    Dal Bello, Maria Giovanna
    Truini, Anna
    Rijavec, Erika
    Biello, Federica
    Sini, Claudio
    Burrafato, Giovanni
    Maggioni, Claudia
    Barletta, Giulia
    Grossi, Francesco
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (05)
  • [33] Detection of EGFR mutations in circulating cell-free DNA of non-small cell lung cancer patients by next-generation sequencing
    Suzawa, Ken
    Tomida, Shuta
    Matsubara, Takahiro
    Ohashi, Kadoaki
    Maki, Yuho
    Yamamoto, Hiromasa
    Morita, Mizuki
    Soh, Junichi
    Asano, Hiroaki
    Tsukuda, Kazunori
    Kiura, Katuyuki
    Miyoshi, Shinichiro
    Toyooka, Shinichi
    CANCER RESEARCH, 2016, 76
  • [34] Circulating DNA is a Useful Prognostic Factor in Patients with Advanced Non-small Cell Lung Cancer
    Sirera, Rafael
    Bremnes, Roy M.
    Cabrera, Andrea
    Jantus-Lewintre, Eloisa
    Sanmartin, Elena
    Blasco, Ana
    del Pozo, Nieves
    Rosell, Rafael
    Guijarro, Ricardo
    Galbis, Jose
    Javier Sanchez, Jose
    Camps, Carlos
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (02) : 286 - 290
  • [35] Relationship between circulating tumour cell count and prognosis following chemotherapy in patients with advanced non-small-cell lung cancer
    Zhang, Zixuan
    Xiao, Yi
    Zhao, Jing
    Chen, Minjiang
    Xu, Yan
    Zhong, Wei
    Xing, Jia
    Wang, Mengzhao
    RESPIROLOGY, 2016, 21 (03) : 519 - 525
  • [36] Cell-free circulating tumor DNA in plasma of non-small cell lung cancer patients: The role in EGFR T790 M mutation testing
    Sekerus, V.
    Stojanovic, G.
    Bursac, D.
    Tegeltija, D.
    Stolic, M.
    Andrijevic, I.
    CLINICA CHIMICA ACTA, 2019, 493 : S574 - S574
  • [37] Clinical significance of plasma free DNA in patients with non-small cell lung cancer
    Ma, Lanxiang
    Du, Jie
    Sui, Yongjie
    Wang, Shuili
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2019, 47 (11) : 5593 - 5600
  • [38] Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer
    Paci, Massimiliano
    Maramotti, Sally
    Bellesia, Enrica
    Formisano, Debora
    Albertazzi, Laura
    Ricchetti, Tommaso
    Ferrari, Guglielmo
    Annessi, Valerio
    Lasagni, Daniela
    Carbonelli, Cristiano
    De Franco, Salvatore
    Brini, Maria
    Sgarbi, Giorgio
    Lodi, Renzo
    LUNG CANCER, 2009, 64 (01) : 92 - 97
  • [39] Estimation of prognosis by circulating biomarkers in patients with non-small cell lung cancer
    Holdenrieder, Stefan
    Nagel, Dorothea
    Stieber, Petra
    CANCER BIOMARKERS, 2010, 6 (3-4) : 179 - 190
  • [40] Possible application of circulating free tumor DNA in non-small cell lung cancer patients
    Karachaliou, Niki
    Sosa, Aaron E.
    Angel Molina, Miguel
    Centelles Ruiz, Margarita
    Rosell, Rafael
    JOURNAL OF THORACIC DISEASE, 2017, 9 : S1364 - S1372